Andreas Fritsche
Andreas Fritsche
Zugehörigkeit unbekannt
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Identification and characterization of metabolically benign obesity in humans
N Stefan, K Kantartzis, J Machann, F Schick, C Thamer, K Rittig, ...
Archives of internal medicine 168 (15), 1609-1616, 2008
Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach
A Floegel, N Stefan, Z Yu, K Mühlenbruch, D Drogan, HG Joost, A Fritsche, ...
Diabetes 62 (2), 639-648, 2013
Glucagon-like peptide 1 (GLP-1)
TD Müller, B Finan, SR Bloom, D D'Alessio, DJ Drucker, PR Flatt, ...
Molecular metabolism 30, 72-130, 2019
Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism
O Tschritter, A Fritsche, C Thamer, M Haap, F Shirkavand, S Rahe, ...
Diabetes 52 (2), 239-243, 2003
Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children
TO Kilpeläinen, L Qi, S Brage, SJ Sharp, E Sonestedt, E Demerath, ...
PLoS medicine 8 (11), e1001116, 2011
α2-Heremans-Schmid Glycoprotein/ Fetuin-A Is Associated With Insulin Resistance and Fat Accumulation in the Liver in Humans
N Stefan, AM Hennige, H Staiger, J Machann, F Schick, SM Kröber, ...
Diabetes care 29 (4), 853-857, 2006
Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes
J Rosenstock, G Dailey, M Massi-Benedetti, A Fritsche, Z Lin, A Salzman
Diabetes care 28 (4), 950-955, 2005
Association of the TG polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes
M Stumvoll, O Tschritter, A Fritsche, H Staiger, W Renn, M Weisser, ...
Diabetes 51 (1), 37-41, 2002
An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes
MB Schulze, K Hoffmann, H Boeing, J Linseisen, S Rohrmann, M Mohlig, ...
Diabetes care 30 (3), 510-515, 2007
Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes: a randomized …
A Fritsche, MA Schweitzer, HU Hring, 4001 Study Group*
Annals of internal medicine 138 (12), 952-959, 2003
Plasma fetuin-A levels and the risk of type 2 diabetes
N Stefan, A Fritsche, C Weikert, H Boeing, HG Joost, HU Häring, ...
Diabetes 57 (10), 2762-2767, 2008
Brain insulin resistance at the crossroads of metabolic and cognitive disorders in humans
S Kullmann, M Heni, M Hallschmid, A Fritsche, H Preissl, HU Häring
Physiological reviews, 2016
Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms
SA Schäfer, O Tschritter, F Machicao, C Thamer, N Stefan, B Gallwitz, ...
Diabetologia 50, 2443-2450, 2007
Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke
C Weikert, N Stefan, MB Schulze, T Pischon, K Berger, HG Joost, ...
Circulation 118 (24), 2555-2562, 2008
Fetuin-A induces cytokine expression and suppresses adiponectin production
AM Hennige, H Staiger, C Wicke, F Machicao, A Fritsche, HU Häring, ...
PloS one 3 (3), e1765, 2008
Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene
K Kantartzis, A Peter, F Machicao, J Machann, S Wagner, I Königsrainer, ...
Diabetes 58 (11), 2616-2623, 2009
Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times
M Stumvoll, T Van Haeften, A Fritsche, J Gerich
Diabetes care 24 (4), 796, 2001
Processing of food pictures: influence of hunger, gender and calorie content
S Frank, N Laharnar, S Kullmann, R Veit, C Canova, YL Hegner, ...
Brain research 1350, 159-166, 2010
High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease
K Kantartzis, C Thamer, A Peter, J Machann, F Schick, C Schraml, ...
Gut 58 (9), 1281-1288, 2009
Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion
K Kirchhoff, F Machicao, A Haupt, SA Schäfer, O Tschritter, H Staiger, ...
Diabetologia 51, 597-601, 2008
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20